|
CAI Caris Life Sciences Inc 2019410 |
| Balance Sheet |
|
Current Assets
|
$1,057,828,000.00 |
|
Assets
|
$1,229,620,000.00 |
|
Current Liabilities
|
$191,437,000.00 |
|
Liabilities
|
$637,886,000.00 |
|
Equity
|
$591,734,000.00 |
|
Shares Out
|
282582915.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$61,353,000.00 |
|
Investing Cash Flow
|
$-132,534,000.00 |
| Market Analysis |
Market Cap
|
$9,152,860,616.85 |
|
Price
|
$35.58 |
|
BVPS
|
2.09 |
|
PB
|
15.50 |
|
PS
|
6.58 |
|
FCF
|
$28,936,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:13 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
0.28 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
0.00 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-7.97 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
0.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CAI documents filed with the SEC.
CAI Filings
Clear
